Mercator Medical S.A.
MRC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 449 | PLN 398 | PLN 482 | PLN 982 |
| - Cash | PLN 123 | PLN 217 | PLN 223 | PLN 340 |
| + Debt | PLN 5 | PLN 5 | PLN 3 | PLN 5 |
| Enterprise Value | PLN 330 | PLN 186 | PLN 262 | PLN 647 |
| Revenue | PLN 543 | PLN 469 | PLN 543 | PLN 1,727 |
| % Growth | 15.7% | -13.5% | -68.6% | – |
| Gross Profit | PLN 141 | PLN 103 | PLN 88 | PLN 684 |
| % Margin | 26% | 21.9% | 16.3% | 39.6% |
| EBITDA | -PLN 5 | -PLN 51 | -PLN 160 | PLN 497 |
| % Margin | -0.9% | -11% | -29.4% | 28.8% |
| Net Income | PLN 51 | -PLN 20 | -PLN 190 | PLN 447 |
| % Margin | 9.4% | -4.2% | -35% | 25.9% |
| EPS Diluted | 5.44 | -2.05 | -19.41 | 44.15 |
| % Growth | 365.4% | 89.4% | -144% | – |
| Operating Cash Flow | -PLN 72 | -PLN 0 | PLN 41 | PLN 503 |
| Capital Expenditures | -PLN 19 | -PLN 39 | -PLN 110 | -PLN 177 |
| Free Cash Flow | -PLN 91 | -PLN 39 | -PLN 69 | PLN 326 |